The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Livestock Vaccine Market Research Report 2024
Synopsis
The global Livestock Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccine.
Report Scope
The Livestock Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Livestock Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Livestock Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer HealthCare AG
Merck Animal Health
Virbac SA
Zoetis
Ceva Sante Animale
Boehringer Ingelheim
Vaxxinova®
Elanco
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Jinyu Biotechnology
Harbin Pharmaceutical Group
Segment by Type
Livestock
Poultry
Segment by Application
Farm
Laboratory
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Livestock Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Livestock Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Livestock Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccine.
Report Scope
The Livestock Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Livestock Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Livestock Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer HealthCare AG
Merck Animal Health
Virbac SA
Zoetis
Ceva Sante Animale
Boehringer Ingelheim
Vaxxinova®
Elanco
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Jinyu Biotechnology
Harbin Pharmaceutical Group
Segment by Type
Livestock
Poultry
Segment by Application
Farm
Laboratory
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Livestock Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Livestock Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Livestock Vaccine Market Overview
1.1 Product Overview and Scope of Livestock Vaccine
1.2 Livestock Vaccine Segment by Type
1.2.1 Global Livestock Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Livestock
1.2.3 Poultry
1.3 Livestock Vaccine Segment by Application
1.3.1 Global Livestock Vaccine Market Value by Application: (2024-2030)
1.3.2 Farm
1.3.3 Laboratory
1.4 Global Livestock Vaccine Market Size Estimates and Forecasts
1.4.1 Global Livestock Vaccine Revenue 2019-2030
1.4.2 Global Livestock Vaccine Sales 2019-2030
1.4.3 Global Livestock Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Livestock Vaccine Market Competition by Manufacturers
2.1 Global Livestock Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Livestock Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Livestock Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Livestock Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Livestock Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Livestock Vaccine, Product Type & Application
2.7 Livestock Vaccine Market Competitive Situation and Trends
2.7.1 Livestock Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Livestock Vaccine Players Market Share by Revenue
2.7.3 Global Livestock Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Livestock Vaccine Retrospective Market Scenario by Region
3.1 Global Livestock Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Livestock Vaccine Global Livestock Vaccine Sales by Region: 2019-2030
3.2.1 Global Livestock Vaccine Sales by Region: 2019-2024
3.2.2 Global Livestock Vaccine Sales by Region: 2025-2030
3.3 Global Livestock Vaccine Global Livestock Vaccine Revenue by Region: 2019-2030
3.3.1 Global Livestock Vaccine Revenue by Region: 2019-2024
3.3.2 Global Livestock Vaccine Revenue by Region: 2025-2030
3.4 North America Livestock Vaccine Market Facts & Figures by Country
3.4.1 North America Livestock Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Livestock Vaccine Sales by Country (2019-2030)
3.4.3 North America Livestock Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Livestock Vaccine Market Facts & Figures by Country
3.5.1 Europe Livestock Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Livestock Vaccine Sales by Country (2019-2030)
3.5.3 Europe Livestock Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Livestock Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Livestock Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Livestock Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Livestock Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Livestock Vaccine Market Facts & Figures by Country
3.7.1 Latin America Livestock Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Livestock Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Livestock Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Livestock Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Livestock Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Livestock Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Livestock Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Livestock Vaccine Sales by Type (2019-2030)
4.1.1 Global Livestock Vaccine Sales by Type (2019-2024)
4.1.2 Global Livestock Vaccine Sales by Type (2025-2030)
4.1.3 Global Livestock Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Livestock Vaccine Revenue by Type (2019-2030)
4.2.1 Global Livestock Vaccine Revenue by Type (2019-2024)
4.2.2 Global Livestock Vaccine Revenue by Type (2025-2030)
4.2.3 Global Livestock Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Livestock Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Livestock Vaccine Sales by Application (2019-2030)
5.1.1 Global Livestock Vaccine Sales by Application (2019-2024)
5.1.2 Global Livestock Vaccine Sales by Application (2025-2030)
5.1.3 Global Livestock Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Livestock Vaccine Revenue by Application (2019-2030)
5.2.1 Global Livestock Vaccine Revenue by Application (2019-2024)
5.2.2 Global Livestock Vaccine Revenue by Application (2025-2030)
5.2.3 Global Livestock Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Livestock Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer HealthCare AG
6.1.1 Bayer HealthCare AG Corporation Information
6.1.2 Bayer HealthCare AG Description and Business Overview
6.1.3 Bayer HealthCare AG Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer HealthCare AG Livestock Vaccine Product Portfolio
6.1.5 Bayer HealthCare AG Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Animal Health Livestock Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Virbac SA
6.3.1 Virbac SA Corporation Information
6.3.2 Virbac SA Description and Business Overview
6.3.3 Virbac SA Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Virbac SA Livestock Vaccine Product Portfolio
6.3.5 Virbac SA Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Livestock Vaccine Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Ceva Sante Animale
6.5.1 Ceva Sante Animale Corporation Information
6.5.2 Ceva Sante Animale Description and Business Overview
6.5.3 Ceva Sante Animale Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ceva Sante Animale Livestock Vaccine Product Portfolio
6.5.5 Ceva Sante Animale Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Livestock Vaccine Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Vaxxinova®
6.6.1 Vaxxinova® Corporation Information
6.6.2 Vaxxinova® Description and Business Overview
6.6.3 Vaxxinova® Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vaxxinova® Livestock Vaccine Product Portfolio
6.7.5 Vaxxinova® Recent Developments/Updates
6.8 Elanco
6.8.1 Elanco Corporation Information
6.8.2 Elanco Description and Business Overview
6.8.3 Elanco Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Elanco Livestock Vaccine Product Portfolio
6.8.5 Elanco Recent Developments/Updates
6.9 MEVAC
6.9.1 MEVAC Corporation Information
6.9.2 MEVAC Description and Business Overview
6.9.3 MEVAC Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 MEVAC Livestock Vaccine Product Portfolio
6.9.5 MEVAC Recent Developments/Updates
6.10 Venky's
6.10.1 Venky's Corporation Information
6.10.2 Venky's Description and Business Overview
6.10.3 Venky's Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Venky's Livestock Vaccine Product Portfolio
6.10.5 Venky's Recent Developments/Updates
6.11 Japfa Comfeed Indonesia
6.11.1 Japfa Comfeed Indonesia Corporation Information
6.11.2 Japfa Comfeed Indonesia Livestock Vaccine Description and Business Overview
6.11.3 Japfa Comfeed Indonesia Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Japfa Comfeed Indonesia Livestock Vaccine Product Portfolio
6.11.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.12 Nisseiken
6.12.1 Nisseiken Corporation Information
6.12.2 Nisseiken Livestock Vaccine Description and Business Overview
6.12.3 Nisseiken Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nisseiken Livestock Vaccine Product Portfolio
6.12.5 Nisseiken Recent Developments/Updates
6.13 Jinyu Biotechnology
6.13.1 Jinyu Biotechnology Corporation Information
6.13.2 Jinyu Biotechnology Livestock Vaccine Description and Business Overview
6.13.3 Jinyu Biotechnology Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jinyu Biotechnology Livestock Vaccine Product Portfolio
6.13.5 Jinyu Biotechnology Recent Developments/Updates
6.14 Harbin Pharmaceutical Group
6.14.1 Harbin Pharmaceutical Group Corporation Information
6.14.2 Harbin Pharmaceutical Group Livestock Vaccine Description and Business Overview
6.14.3 Harbin Pharmaceutical Group Livestock Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Harbin Pharmaceutical Group Livestock Vaccine Product Portfolio
6.14.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Livestock Vaccine Industry Chain Analysis
7.2 Livestock Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Livestock Vaccine Production Mode & Process
7.4 Livestock Vaccine Sales and Marketing
7.4.1 Livestock Vaccine Sales Channels
7.4.2 Livestock Vaccine Distributors
7.5 Livestock Vaccine Customers
8 Livestock Vaccine Market Dynamics
8.1 Livestock Vaccine Industry Trends
8.2 Livestock Vaccine Market Drivers
8.3 Livestock Vaccine Market Challenges
8.4 Livestock Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
